A detailed history of Fortem Financial Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fortem Financial Group, LLC holds 2,038 shares of LLY stock, worth $1.52 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
2,038
Previous 2,038 -0.0%
Holding current value
$1.52 Million
Previous $1.81 Million -0.0%
% of portfolio
0.75%
Previous 0.75%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $301,134 - $374,407
390 Added 23.67%
2,038 $1.81 Million
Q2 2024

Aug 02, 2024

SELL
$724.87 - $909.04 $48,566 - $60,905
-67 Reduced 3.91%
1,648 $1.49 Million
Q1 2024

May 01, 2024

SELL
$592.2 - $792.28 $27,241 - $36,444
-46 Reduced 2.61%
1,715 $1.33 Million
Q4 2023

Jan 25, 2024

BUY
$525.19 - $619.13 $52,519 - $61,913
100 Added 6.02%
1,761 $1.03 Million
Q3 2023

Oct 10, 2023

SELL
$434.7 - $599.3 $13,910 - $19,177
-32 Reduced 1.89%
1,661 $892,000
Q2 2023

Jul 18, 2023

SELL
$350.74 - $468.98 $31,917 - $42,677
-91 Reduced 5.1%
1,693 $793,000
Q1 2023

Apr 21, 2023

SELL
$310.63 - $364.82 $370,581 - $435,230
-1,193 Reduced 40.07%
1,784 $612,000
Q4 2022

Jan 17, 2023

SELL
$321.55 - $374.67 $9,646 - $11,240
-30 Reduced 1.0%
2,977 $0
Q3 2022

Nov 01, 2022

SELL
$296.48 - $337.87 $13,638 - $15,542
-46 Reduced 1.51%
3,007 $972,000
Q2 2022

Jul 25, 2022

SELL
$278.73 - $327.27 $4.16 Million - $4.89 Million
-14,929 Reduced 83.02%
3,053 $990,000
Q1 2022

Apr 27, 2022

BUY
$234.69 - $291.66 $145,977 - $181,412
622 Added 3.58%
17,982 $5.15 Million
Q4 2021

Jan 20, 2022

BUY
$224.85 - $279.04 $97,360 - $120,824
433 Added 2.56%
17,360 $4.8 Million
Q3 2021

Oct 15, 2021

BUY
$221.6 - $272.71 $58,945 - $72,540
266 Added 1.6%
16,927 $3.91 Million
Q2 2021

Jul 14, 2021

BUY
$180.55 - $233.54 $221,715 - $286,787
1,228 Added 7.96%
16,661 $3.82 Million
Q1 2021

Apr 20, 2021

SELL
$164.32 - $212.72 $74,436 - $96,362
-453 Reduced 2.85%
15,433 $2.88 Million
Q4 2020

Jan 29, 2021

BUY
$130.46 - $172.63 $40,051 - $52,997
307 Added 1.97%
15,886 $2.68 Million
Q3 2020

Oct 15, 2020

BUY
$146.22 - $169.13 $1.6 Million - $1.85 Million
10,932 Added 235.25%
15,579 $2.31 Million
Q2 2020

Jul 14, 2020

SELL
$136.42 - $164.18 $30,285 - $36,447
-222 Reduced 4.56%
4,647 $763,000
Q1 2020

Apr 23, 2020

SELL
$119.05 - $147.35 $228,218 - $282,469
-1,917 Reduced 28.25%
4,869 $675,000
Q4 2019

Feb 11, 2020

BUY
$106.92 - $132.43 $154,927 - $191,891
1,449 Added 27.15%
6,786 $892,000
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $354,649 - $385,767
3,321 Added 164.73%
5,337 $597,000
Q2 2019

Aug 09, 2019

BUY
$110.79 - $129.32 $29,248 - $34,140
264 Added 15.07%
2,016 $223,000
Q1 2019

May 13, 2019

BUY
$111.31 - $131.02 $195,015 - $229,547
1,752 New
1,752 $227,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fortem Financial Group, LLC Portfolio

Follow Fortem Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortem Financial Group, LLC with notifications on news.